The study failed to achieve its primary endpoint – treatment with the drug failed to demonstrate a significant improvement over placebo in alleviating depression symptoms, as measured by the ...
Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... or selective serotonin reuptake inhibitor drugs can take weeks to elevate mood, placing severely ...